Divi’s Q2 FY27 Profit Jumps 64% as Revenue Hits ₹3,676 Crore
Divi’s Laboratories reported a 63.6% rise in Q2 FY27 consolidated profit to ₹1,127 crore as revenue from operations grew 35.4% to ₹3,676 crore.
Divi’s Laboratories reported a 63.6% rise in Q2 FY27 consolidated profit to ₹1,127 crore as revenue from operations grew 35.4% to ₹3,676 crore.
Gland Pharma Q2 FY27 net profit rises 58% to ₹291 crore as revenue grows 23% to ₹1,834 crore, led by 31% CDMO growth and a 42% jump in US sales.
Rajendra Kshirsagar has been appointed Chief Information Officer (CIO) of Star Hospitals, the Hyderabad-based multispecialty and quaternary care hospital group. […]
Laurus Labs reported Q2 FY27 net profit of ₹441 crore, up 126%, on revenue of ₹2,206 crore, as CDMO revenue rose 75% to ₹904 crore and EBITDA margin widened to 34.5%. The Hyderabad drugmaker also agreed to take a 60% stake in Montreal-based Galenvs Sciences to deepen its oligonucleotide capabilities.
Apollo Hospitals has launched an AI-assisted, 360-degree stroke care programme in Hyderabad on World Stroke Day, linking 5G-connected ambulances, rapid assessment, neuro-ICU monitoring, rehabilitation and home follow-up.
Hyderabad’s Sindhu Hospitals has signed an MoU with MedicaMetrix’s BeyondA1C to introduce AI-enabled, point-of-care nerve conduction tests that screen diabetic, dialysis and chemotherapy patients for hidden complications, a first for India.
MSD, the trade name of Merck & Co., Inc., has appointed Vidhya Sundaram as Associate Vice President, Global Technology Centers […]
Hyderabad: Reinforcing its status as India’s pharmaceutical capital, Hyderabad is rapidly emerging as a global hub for healthcare innovation, pharmaceutical […]
Hyderabad, Telangana: The India Pharma Expo 2026, held from 23rd April alongside the NextGen Pharma Summit & Awards, concluded on […]
Hyderabad, Telangana: Building on the strong momentum of Day 1, India Pharma Expo & Summit 2026, being held alongside the […]
Hyderabad, Telangana: The much-awaited India Pharma Expo 2026, being held alongside the NextGen Pharma Summit & Awards, begins today, 23rd […]
Swiss drugmaker Novartis has scaled its Global Capability Centre (GCC) in Hyderabad into its largest global operations hub, strengthening India’s […]
Motilal Oswal Alternates has invested $72 million in Hyderabad-based medical devices company Sensa Core, marking a strong vote of confidence […]